3rd Annual Innate Killer Summit Europe

Key Topics

• Bringing the Next Wave of Innate Immunotherapies to Market
• Utilising the Innate Immune System to Overcome Tumour Resistance Mechanisms & Facilitate a wider Immune Response
• Reconsidering Innate Cell Scarcity & Phenotypic Complexity to Promote an Effective & Efficient Engraftment Strategy
• Evaluating the Role of Genetic Engineering to Reduce Immunogenicity & Increase Persistence of Innate Cell Therapies
• Bringing the Next Wave of Innate Immunotherapies to Market
• Utilising the Innate Immune System to Overcome Tumour Resistance Mechanisms & Facilitate a wider Immune Response
• Reconsidering Innate Cell Scarcity & Phenotypic Complexity to Promote an Effective & Efficient Engraftment Strategy
• Evaluating the Role of Genetic Engineering to Reduce Immunogenicity & Increase Persistence of Innate Cell Therapies
• Looking Beyond NK Allogeneic Therapies with Cell Engager & Combined Modality Strategies
• Re-Imagining Predictive Modelling to Break Translational Barriers in Innate Cell Therapy Development
• Harnessing the Power of Myeloid Cells to Achieve Clinical Efficacy in the Next Generation of Innate Cell Therapies